Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

812 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of nitric oxide synthase aggravates non-alcoholic steatohepatitis and atherosclerosis in SHRSP5/Dmcr rat via acceleration of abnormal lipid metabolism.
Sato I, Yamamoto S, Kakimoto M, Fujii M, Honma K, Kumazaki S, Matsui M, Nakayama H, Kirihara S, Ran S, Usui S, Shinohata R, Kitamori K, Hirohata S, Watanabe S. Sato I, et al. Among authors: honma k. Pharmacol Rep. 2022 Aug;74(4):669-683. doi: 10.1007/s43440-022-00380-1. Epub 2022 Jul 12. Pharmacol Rep. 2022. PMID: 35819592
Increased Glycine-conjugated and Unconjugated Bile Acid Levels Associated with Aggravation of Nonalcoholic Steatohepatitis and Cardiovascular Disease in SHRSP5/Dmcr Rat.
Yamamoto S, Sato I, Fujii M, Kakimoto M, Honma K, Akiyama N, Sakai M, Fukuhama N, Kumazaki S, Hirohata S, Kitamori K, Yamori Y, Watanabe S. Yamamoto S, et al. Among authors: honma k. Acta Med Okayama. 2023 Feb;77(1):29-36. doi: 10.18926/AMO/64358. Acta Med Okayama. 2023. PMID: 36849143 Free article.
Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model.
Yamamoto S, Sato I, Fujii M, Kakimoto M, Honma K, Kirihara S, Nakayama H, Fukuoka T, Tamura S, Ueda M, Hirohata S, Watanabe S. Yamamoto S, et al. Among authors: honma k. Can J Physiol Pharmacol. 2023 Sep 1;101(9):455-465. doi: 10.1139/cjpp-2022-0532. Epub 2023 May 24. Can J Physiol Pharmacol. 2023. PMID: 37224568
A Rare Case of Autoimmune-Mediated Lecithin:Cholesterol Acyltransferase Insufficiency Manifesting as the Acute Onset of Extremely Hypo-High-Density Lipoprotein-Cholesterolemia and Spontaneous Improvement: A Case Report with a Review of the Literature.
Tamaki A, Kuroda M, Yonaha K, Ishiki Y, Uehara M, Nakayama Y, Honma KI, Chinen R, Uema T, Okamoto S, Miyoshi J, Kirinashizawa M, Sato K, Aohara T, Yamamoto M, Maezawa Y, Yokote K, Masuzaki H. Tamaki A, et al. Among authors: honma ki. J Atheroscler Thromb. 2024 Dec 10. doi: 10.5551/jat.65298. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 39662947 Free article.
Lorlatinib overcomes alectinib-induced hemolytic anemia in an ALK fusion positive non-small-cell lung cancer patient with severe tumor-associated liver failure: A case report.
Kunimasa K, Miyazaki A, Tamiya M, Inoue T, Kawamura T, Tanaka T, Futamura S, Komuta K, Nagata S, Honma K, Ohkawa K, Nishino K. Kunimasa K, et al. Among authors: honma k. Thorac Cancer. 2024 Dec;15(36):2570-2574. doi: 10.1111/1759-7714.15487. Epub 2024 Nov 11. Thorac Cancer. 2024. PMID: 39527462 Free PMC article.
Salvage treatment for local recurrence after endoscopic resection for superficial nonampullary duodenal epithelial tumors.
Kawakami Y, Kanesaka T, Kitagawa D, Yoshii S, Asada Y, Ueda T, Ninomiya T, Kizawa A, Okubo Y, Tani Y, Shichijo S, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T, Kitamura M, Honma K, Ishihara R. Kawakami Y, et al. Among authors: honma k. Gastrointest Endosc. 2023 Oct 27:S0016-5107(23)03026-2. doi: 10.1016/j.gie.2023.10.049. Online ahead of print. Gastrointest Endosc. 2023. PMID: 39491112
812 results